Literature DB >> 1365659

Effect of 5-HT agonists on rats fed single diets with varying proportions of carbohydrate and protein.

S Luo1, E T Li.   

Abstract

Low doses of 5-HT agonists have been shown to selectively suppress carbohydrate intake in rats given dietary choices. To investigate further the relationship between dietary macronutrient composition and 5-HT-induced anorexia, the present study examined the effects of three 5-HT agonists on rats fed single isocaloric diets containing varying proportions of carbohydrate (CHO) and protein (PRO). Rats were habituated to eat one of the three diets (73.5% CHO--10% PRO, 58.5% CHO--25% PRO or 43.5% CHO--40% PRO) during the dark period (1900-0700 h). Saline or 5-HT agonists (fluoxetine, RU 24969 and dexfenfluramine) were administered intraperitoneally at 1845 hours, 15 min prior to food access. At the doses used, food intake was significantly affected only during the first hour of eating. All 5-HT agonists caused dose-dependent decreases in food intake (P < 0.01). The magnitude of decrease, however, was significantly influenced by diet composition. Reduction in intake was greatest in rats fed the 73.5% CHO--10% PRO diet. Thus, rats chronically fed a diet high in carbohydrate content were more sensitive to the anorectic effect of 5-HT agonists than rats fed diets containing moderate to low levels of carbohydrate.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1365659     DOI: 10.1007/bf02245502

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  28 in total

1.  Drugs that enhance central serotoninergic transmission diminish elective carbohydrate consumption by rats.

Authors:  J J Wurtman; R J Wurtman
Journal:  Life Sci       Date:  1979-03-05       Impact factor: 5.037

2.  Effects of repeated administration of serotonergic agonists on diet selection and body weight in rats.

Authors:  S Q Luo; E T Li
Journal:  Pharmacol Biochem Behav       Date:  1991-03       Impact factor: 3.533

3.  Medial hypothalamic serotonin: role in circadian patterns of feeding and macronutrient selection.

Authors:  S F Leibowitz; G F Weiss; U A Walsh; D Viswanath
Journal:  Brain Res       Date:  1989-11-27       Impact factor: 3.252

4.  Selective increase in carbohydrate intake by rats treated with 8-hydroxy-2-(di-n-propylamino)-tetraline or buspirone.

Authors:  S Q Luo; T Ransom; E T Li
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

5.  Peripheral and central mechanisms of action of serotoninergic anorectic drugs.

Authors:  M O Carruba; P Mantegazza; M Memo; C Missale; M Pizzi; P F Spano
Journal:  Appetite       Date:  1986       Impact factor: 3.868

Review 6.  Carbohydrate taste, appetite, and obesity: an overview.

Authors:  A Sclafani
Journal:  Neurosci Biobehav Rev       Date:  1987       Impact factor: 8.989

7.  Effects of carbohydrate and protein administration on rat tryptophan and 5-hydroxytryptamine: differential effects on the brain, intestine, pineal, and pancreas.

Authors:  K L Teff; S N Young
Journal:  Can J Physiol Pharmacol       Date:  1988-06       Impact factor: 2.273

8.  Effect of hypothalamic and peripheral fluoxetine injection on natural patterns of macronutrient intake in the rat.

Authors:  G F Weiss; N Rogacki; A Fueg; D Buchen; J S Suh; D T Wong; S F Leibowitz
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

9.  The dorsal and medial raphe projections to the substantia nigra in the rat: electrophysiological, biochemical and behavioural observations.

Authors:  A Dray; J Davies; N R Oakley; P Tongroach; S Vellucci
Journal:  Brain Res       Date:  1978-08-11       Impact factor: 3.252

10.  Brain serotonin content: increase following ingestion of carbohydrate diet.

Authors:  J D Fernstrom; R J Wurtman
Journal:  Science       Date:  1971-12-03       Impact factor: 47.728

View more
  1 in total

Review 1.  Pharmacological approaches for the treatment of obesity.

Authors:  José-Antonio Fernández-López; Xavier Remesar; Màrius Foz; Marià Alemany
Journal:  Drugs       Date:  2002       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.